1、 GASPARRI F, WANG N, SKOG S, et al. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays [J]. Eur J Cell Biol, 2009,88(12):779-785. GASPARRI F, WANG N, SKOG S, et al. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays [J]. Eur J Cell Biol, 2009,88(12):779-785.
2、 WEI Y T, LUO Y Z, FENG Z Q, et al. TK1 overexpression is associated with the poor outcomes of lung cancer patients: a systematic review and meta-analysis [J]. Biomark Med, 2018,12(4):403-413. WEI Y T, LUO Y Z, FENG Z Q, et al. TK1 overexpression is associated with the poor outcomes of lung cancer patients: a systematic review and meta-analysis [J]. Biomark Med, 2018,12(4):403-413.
3、 WEAGEL E G, MENG W, TOWNSEND M H, et al. Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia [J]. Onco Targets and Therapy, 2017,10: 4335-4367. WEAGEL E G, MENG W, TOWNSEND M H, et al. Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia [J]. Onco Targets and Therapy, 2017,10: 4335-4367.
4、 田果平.血清胸苷激酶1(TK1)水平变化对小细胞肺癌(NSCLC)患者临床诊断价值观察 临床医药文献电子杂志 [J]. 2018,(72): 156-159. 田果平.血清胸苷激酶1(TK1)水平变化对小细胞肺癌(NSCLC)患者临床诊断价值观察 临床医药文献电子杂志 [J]. 2018,(72): 156-159.
5、 张伟,龚磊杨,锦雷,等. 血清胸苷激酶1在食管鳞癌诊治中的应用价值 [J]. 安徽医学杂志 [J],2018,39(9): 1125-1127. 张伟,龚磊杨,锦雷,等. 血清胸苷激酶1在食管鳞癌诊治中的应用价值 [J]. 安徽医学杂志 [J],2018,39(9): 1125-1127.
6、 BROCKENBROUGH J S, MORIHARA J K, HAWES S E, et al. Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation [J]. J Histochem Cytochem,2009,57(11): 1087-1097. BROCKENBROUGH J S, MORIHARA J K, HAWES S E, et al. Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation [J]. J Histochem Cytochem,2009,57(11): 1087-1097.
7、 KEMIK O, KEMIK A S, PURISA S, et al. Serum thymidine kinase is associated with gastricadeno carcinoma [J]. Bratisl Lek Listv, 2011, 112(9): 510-511. KEMIK O, KEMIK A S, PURISA S, et al. Serum thymidine kinase is associated with gastricadeno carcinoma [J]. Bratisl Lek Listv, 2011, 112(9): 510-511.
8、 ALEGRE M M, ROBISON R A, O'NEILL K L. Thymidine kinase 1 upregulation is an early event in breast tumor formation [J]. J Oncol, 2012,22(3): 1-5. ALEGRE M M, ROBISON R A, O'NEILL K L. Thymidine kinase 1 upregulation is an early event in breast tumor formation [J]. J Oncol, 2012,22(3): 1-5.
9、 JAGARLAMUDI K K, HANSSON L O, ERIKSSON S. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker [J]. BMC Cancer, 2015,15(66): 126-138. JAGARLAMUDI K K, HANSSON L O, ERIKSSON S. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker [J]. BMC Cancer, 2015,15(66): 126-138.
10、 CHEN G, HE C, LI L, et al. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix [J]. BMC Cancer, 2013,13: 249. CHEN G, HE C, LI L, et al. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix [J]. BMC Cancer, 2013,13: 249.
11、 NISMAN B, APPELBAUM L, YUTKIN V, et al. Serum thymidine kinase 1 activity following nephrectomy for renal cell carcinoma and radiofrequency ablation of metastases to lung and liver [J]. Anticancer Res, 2016,36(4): 1791-1797. NISMAN B, APPELBAUM L, YUTKIN V, et al. Serum thymidine kinase 1 activity following nephrectomy for renal cell carcinoma and radiofrequency ablation of metastases to lung and liver [J]. Anticancer Res, 2016,36(4): 1791-1797.
12、 AGARWAL H K, MCELROY C A, SJUVARSSON E, et al. Synthesis of N3substitutedcarboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1 [J]. Eur J Med Chem, 2013,60(2): 456-468. AGARWAL H K, MCELROY C A, SJUVARSSON E, et al. Synthesis of N3substitutedcarboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1 [J]. Eur J Med Chem, 2013,60(2): 456-468.
13、 KIRANKUMAR J, SHARIF H, WESTBERG S, et al. High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics [J]. Vet J, 2013, 197(3): 854-860. KIRANKUMAR J, SHARIF H, WESTBERG S, et al. High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics [J]. Vet J, 2013, 197(3): 854-860.
14、 MUTAHIR Z, CLAUSEN A R, ANDERSSOn K M, et al. Thymidine kinase 1 regulatory fine-tuning throughtetramer formation [J]. FEBS J, 2013, 280(6): 1531-1541. MUTAHIR Z, CLAUSEN A R, ANDERSSOn K M, et al. Thymidine kinase 1 regulatory fine-tuning throughtetramer formation [J]. FEBS J, 2013, 280(6): 1531-1541.
15、 CARLSSON L, LARSSON A. Elevated levels of thymidine kinase 1 pepfide in serum from patients with breast cancer [J]. Ups J Med Sci, 2009, 144(2): 116-120. CARLSSON L, LARSSON A. Elevated levels of thymidine kinase 1 pepfide in serum from patients with breast cancer [J]. Ups J Med Sci, 2009, 144(2): 116-120.
16、 HEFFNER J E,BROWN L K,BARBIERI C A. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions [J]. Chest,1997,111(4): 970-980. HEFFNER J E,BROWN L K,BARBIERI C A. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions [J]. Chest,1997,111(4): 970-980.
17、 LIGHT R W. Update on tuberculous pleural effusion [J]. Respirol,2010,15(3): 451-458. LIGHT R W. Update on tuberculous pleural effusion [J]. Respirol,2010,15(3): 451-458.
18、 WONG C F,YEW W W,LEUNG S K,et al. Assay of pleural fluid interleukin-6,tumour necrosis factor-alpha and interferongamma in the diagnosis and outcome correlation of tuberculous effusion [J]. Respir Med,2003,97(12): 1289-1295. WONG C F,YEW W W,LEUNG S K,et al. Assay of pleural fluid interleukin-6,tumour necrosis factor-alpha and interferongamma in the diagnosis and outcome correlation of tuberculous effusion [J]. Respir Med,2003,97(12): 1289-1295.
19、 DAVIES H E,DAVIES R J,DAVIES C W. Management of pleural infection in adults: British thoracic society pleural disease guideline 2010 [J]. Thorax,2010,65(suppl 2): ii41-ii53. DAVIES H E,DAVIES R J,DAVIES C W. Management of pleural infection in adults: British thoracic society pleural disease guideline 2010 [J]. Thorax,2010,65(suppl 2): ii41-ii53.
20、 MOLINA R,AUGé J M,BOSCH X,et al. Usefulness of serum tumor markers, including progastrin-releasing peptide,in patients with lung cancer: Correlation with histology [ J]. Tumour Biol,2009,30 (3): 121-129. MOLINA R,AUGé J M,BOSCH X,et al. Usefulness of serum tumor markers, including progastrin-releasing peptide,in patients with lung cancer: Correlation with histology [ J]. Tumour Biol,2009,30 (3): 121-129.
21、 JAGARLAMUDI K K,HANSSON L O,ERIKSSON S. Breast and prostate cancer patients differ significantly in their serum thymidine kinase 1 (tk1) specific activities compared with those hematological malignancies and blood donors: Implications of using serum tk1 as a biomarker [J]. Bmc Cancer,2015, 15(1): 1-12. JAGARLAMUDI K K,HANSSON L O,ERIKSSON S. Breast and prostate cancer patients differ significantly in their serum thymidine kinase 1 (tk1) specific activities compared with those hematological malignancies and blood donors: Implications of using serum tk1 as a biomarker [J]. Bmc Cancer,2015, 15(1): 1-12.
22、 AUFDERKLAMM S,TODENH?FER T,GAKIS G,et al. Thymidine kinase and cancer monitoring [J]. Cancer Letters, 2012, 316(1): 6-10. AUFDERKLAMM S,TODENH?FER T,GAKIS G,et al. Thymidine kinase and cancer monitoring [J]. Cancer Letters, 2012, 316(1): 6-10.
23、 施焕中. 重视胸腔积液的基础与临床研究 [J]. 中华结核和呼吸杂志,2013,36(5): 323-324. 施焕中. 重视胸腔积液的基础与临床研究 [J]. 中华结核和呼吸杂志,2013,36(5): 323-324.
